Literature DB >> 26982552

Targeting Tumor Cells by Natural Anti-Carbohydrate Antibodies Using Rhamnose-Functionalized Liposomes.

Xuexia Li1,2, Xiongjian Rao1,2, Li Cai3, Xuling Liu1, Huixia Wang1, Weinan Wu1, Chenggang Zhu1, Min Chen4, Peng G Wang4,5, Wen Yi1,2.   

Abstract

Recruitment of antibodies in human immune systems for targeted destruction of tumor cells has emerged as an exciting area of research due to its low occurrence of side effects, high efficacy, and high specificity. The presence of large amounts of anticarbohydrate natural antibodies in human sera has prompted research efforts to utilize carbohydrate epitopes for immune recruitment. Here, we have developed a general strategy for specific targeted destruction of tumor cells based on rhamnose-functionalized liposomes. Tumor cells artificially decorated with rhamnose epitopes were subjected to complement-mediated cytotoxicity in vitro and showed delayed tumor growth in vivo. This study highlights the therapeutic potential for activation of endogenous immune response through cell-surface glycan engineering.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26982552     DOI: 10.1021/acschembio.6b00173

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  11 in total

1.  Nanotechnology for the Development of Nanovaccines in Cancer Immunotherapy.

Authors:  Maria Aurora Grimaudo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Multivalent Antibody-Recruiting Macromolecules: Linking Increased Binding Affinity with Enhanced Innate Immune Killing.

Authors:  Annemiek Uvyn; Bruno G De Geest
Journal:  Chembiochem       Date:  2020-07-10       Impact factor: 3.164

3.  A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behavior.

Authors:  NIcholas T Jacob; Kensaku Anraku; Atsushi Kimishima; Bin Zhou; Karen C Collins; Jonathan W Lockner; Beverley A Ellis; Kim D Janda
Journal:  Chem Commun (Camb)       Date:  2017-07-18       Impact factor: 6.222

4.  Synthetic Antibody-Rhamnose Cluster Conjugates Show Potent Complement-Dependent Cell Killing by Recruiting Natural Antibodies.

Authors:  Chong Ou; Sunaina Kiran Prabhu; Xiao Zhang; Guanghui Zong; Qiang Yang; Lai-Xi Wang
Journal:  Chemistry       Date:  2022-02-21       Impact factor: 5.236

5.  Evidence of Protein Adsorption in Pegylated Liposomes: Influence of Liposomal Decoration.

Authors:  Marc Sangrà; Joan Estelrich; Raimon Sabaté; Alba Espargaró; Maria Antònia Busquets
Journal:  Nanomaterials (Basel)       Date:  2017-02-10       Impact factor: 5.076

6.  Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies.

Authors:  Md Kamal Hossain; Abhishek Vartak; Partha Karmakar; Steven J Sucheck; Katherine A Wall
Journal:  ACS Chem Biol       Date:  2018-07-02       Impact factor: 5.100

Review 7.  Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.

Authors:  Bethany Almeida; Okhil K Nag; Katherine E Rogers; James B Delehanty
Journal:  Molecules       Date:  2020-12-01       Impact factor: 4.411

8.  Metabolic labelling of cancer cells with glycodendrimers stimulate immune-mediated cytotoxicity.

Authors:  David Goyard; Peremobowei Iyanu Diriwari; Nathalie Berthet
Journal:  RSC Med Chem       Date:  2021-11-09

9.  Site-specific C-terminal dinitrophenylation to reconstitute the antibody Fc functions for nanobodies.

Authors:  Haofei Hong; Zhifang Zhou; Kun Zhou; Shaozhong Liu; Zhongwu Guo; Zhimeng Wu
Journal:  Chem Sci       Date:  2019-08-28       Impact factor: 9.825

10.  Aptamer-Functionalized Liposomes as a Potential Treatment for Basal Cell Carcinoma.

Authors:  Anca N Cadinoiu; Delia M Rata; Leonard I Atanase; Oana M Daraba; Daniela Gherghel; Gabriela Vochita; Marcel Popa
Journal:  Polymers (Basel)       Date:  2019-09-18       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.